Aspira Womens Health Inc (NAS:AWH)

$ 0.8599 -0.0301 (-3.38%) Market Cap: 14.33 Mil Enterprise Value: 14.84 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 59/100

Q3 2024 Aspira Women's Health Inc Earnings Call Transcript
Nov 14, 2024

$0.7401 (-9.74%)

Earnings
Q2 2024 Aspira Women's Health Inc Earnings Call Transcript
Aug 12, 2024

$1.13 (-0.88%)

Earnings
Q1 2024 Aspira Women's Health Inc Earnings Call Transcript
May 15, 2024

$2.78 (-4.14%)

Earnings
Q4 2023 Aspira Women's Health Inc Earnings Call Transcript
Mar 28, 2024

$3.1 (-9.62%)

Earnings
Aspira Women's Health Inc RandD Day Transcript
Jan 04, 2024
Q3 2023 Aspira Women's Health Inc Earnings Call Transcript
Nov 13, 2023

$3.72 (-8.82%)

Earnings
Q2 2023 Aspira Women's Health Inc Earnings Call Transcript
Aug 14, 2023

$3.55 (+2.90%)

Earnings
Aspira Women's Health Inc Investor Day Transcript
May 23, 2023
Q1 2023 Aspira Women's Health Inc Earnings Call Transcript
May 11, 2023

$3.85 (-13.87%)

Earnings
Q4 2022 Aspira Women's Health Inc Earnings Call Transcript
Mar 22, 2023

$7.5 (+4.34%)

Earnings
Q3 2022 Aspira Women's Health Inc Earnings Call Transcript
Nov 10, 2022

$5.86 (+6.23%)

Earnings
Q2 2022 Aspira Women's Health Inc Earnings Call Transcript
Aug 10, 2022

$14.55 (-9.35%)

Earnings
Q1 2022 Aspira Women's Health Inc Earnings Call Transcript
May 11, 2022

$6 (-32.36%)

Earnings
Q4 2021 Aspira Women's Health Inc Earnings Call Transcript
Mar 23, 2022

$14.4 (-9.42%)

Earnings
Aspira Women's Health Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 09, 2022
Q3 2021 Aspira Women's Health Inc Earnings Call Transcript
Nov 10, 2021

$41.25 (-15.64%)

Earnings
Q2 2021 Aspira Women's Health Inc Earnings Call Transcript
Aug 12, 2021

$60.15 (-1.96%)

Earnings
Q1 2021 Aspira Women's Health Inc Earnings Call Transcript
May 13, 2021

$72.75 (+1.46%)

Earnings
Q4 2020 Aspira Women's Health Inc Earnings Call Transcript
Mar 25, 2021

$100.65 (+1.67%)

Earnings
Q3 2020 Aspira Women's Health Inc Earnings Call Transcript
Nov 12, 2020

$66.75 (+0.91%)

Earnings
Q2 2020 Aspira Women's Health Inc Earnings Call Transcript
Aug 13, 2020

$60.75 (-2.88%)

Earnings
Vermillion Inc Annual Shareholders Meeting Transcript
Jun 23, 2020
Q1 2020 Vermillion Inc Earnings Call Transcript
May 14, 2020

$32.55 (+13.02%)

Earnings
Q4 2019 Vermillion Inc Earnings Call Transcript
Mar 26, 2020

$11.08 (+4.84%)

Earnings
Q3 2019 Vermillion Inc Earnings Call Transcript
Nov 12, 2019

$9.59 (+3.16%)

Earnings
Q2 2019 Vermillion Inc Earnings Call Transcript
Aug 08, 2019

$9.46 (-3.00%)

Earnings
Q1 2019 Vermillion Inc Earnings Call Transcript
May 14, 2019

$20.1 (+3.88%)

Earnings
Q4 2018 Vermillion Inc Earnings Call Transcript
Mar 28, 2019

$19.35 (+1.57%)

Earnings

Vermillion Inc Annual Shareholders Meeting Transcript

Jun 23, 2020 / 12:00PM GMT

Release Date Price: $69.15 (+2.67%)

Transcript

Operator

Welcome to the Aspira Women's Health, Inc. Annual Meeting of Stockholders. I will now turn the meeting over to Jim LaFrance, Chairman of the Board of Directors of Aspira Women's Health.

James T. LaFrance;s Health Inc.;Independent Chairman of the Board

Aspira Women

'-

Good morning, ladies and gentlemen. I am Jim LaFrance, Chairman of the Board of Directors of Aspira Women's Health, Inc. On June 11 this year, we formally changed our name from Vermilion Inc. to Aspira Women's Health, Inc. It is a pleasure to welcome you to our virtual annual meeting of stockholders.

Before we begin, I would like to note that during the course of this meeting and the question-and-answer period afterwards, I, or other representatives of the company, may make forward-looking statements, which represent the company's current expectations or beliefs concerning future events or the future financial performance of the company. Such statements are predictions only based upon information currently available to the company. Actual events or results

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.